These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 9555099)

  • 1. Interaction of mercaptoundecahydrododecaborate (BSH) with phosphatidylcholine: relevance to boron neutron capture therapy.
    Kageji T; Otersen B; Gabel D; Huiskamp R; Nakagawa Y; Matsumoto K
    Biochim Biophys Acta; 1998 Apr; 1391(3):377-83. PubMed ID: 9555099
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of a novel sodium borocaptate-containing unnatural amino acid as a boron delivery agent for neutron capture therapy of the F98 rat glioma.
    Futamura G; Kawabata S; Nonoguchi N; Hiramatsu R; Toho T; Tanaka H; Masunaga SI; Hattori Y; Kirihata M; Ono K; Kuroiwa T; Miyatake SI
    Radiat Oncol; 2017 Jan; 12(1):26. PubMed ID: 28114947
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subcellular biodistribution of sodium borocaptate (BSH: Na2B12H11SH) in a rat glioma model in boron neutron capture therapy.
    Kageji T; Nagahiro S; Otersen B; Gabel D; Nakaichi M; Nakagawa Y
    J Neurooncol; 2002 Sep; 59(2):135-42. PubMed ID: 12241106
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The acceleration of boron neutron capture therapy using multi-linked mercaptoundecahydrododecaborate (BSH) fused cell-penetrating peptide.
    Michiue H; Sakurai Y; Kondo N; Kitamatsu M; Bin F; Nakajima K; Hirota Y; Kawabata S; Nishiki T; Ohmori I; Tomizawa K; Miyatake S; Ono K; Matsui H
    Biomaterials; 2014 Mar; 35(10):3396-405. PubMed ID: 24452095
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Self-assembling A6K peptide nanotubes as a mercaptoundecahydrododecaborate (BSH) delivery system for boron neutron capture therapy (BNCT).
    Michiue H; Kitamatsu M; Fukunaga A; Tsuboi N; Fujimura A; Matsushita H; Igawa K; Kasai T; Kondo N; Matsui H; Furuya S
    J Control Release; 2021 Feb; 330():788-796. PubMed ID: 33188824
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liposomal formulations containing sodium mercaptoundecahydrododecaborate (BSH) for boron neutron capture therapy.
    Mehta SC; Lai JC; Lu DR
    J Microencapsul; 1996; 13(3):269-79. PubMed ID: 8860683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spectromicroscopy of boron in human glioblastomas following administration of Na2B12H11SH.
    Gilbert B; Perfetti L; Fauchoux O; Redondo J; Baudat PA; Andres R; Neumann M; Steen S; Gabel D; Mercanti D; Ciotti MT; Perfetti P; Margaritondo G; De Stasio G
    Phys Rev E Stat Phys Plasmas Fluids Relat Interdiscip Topics; 2000 Jul; 62(1 Pt B):1110-8. PubMed ID: 11088567
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In Vitro Studies to Define the Cell-Surface and Intracellular Targets of Polyarginine-Conjugated Sodium Borocaptate as a Potential Delivery Agent for Boron Neutron Capture Therapy.
    Fujimura A; Yasui S; Igawa K; Ueda A; Watanabe K; Hanafusa T; Ichikawa Y; Yoshihashi S; Tsuchida K; Kamiya A; Furuya S
    Cells; 2020 Sep; 9(10):. PubMed ID: 32977522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FT-IR measurement of mercaptoundecahydrododecaborate in human plasma.
    Saini P; Lai JC; Lu DR
    J Pharm Biomed Anal; 1994 Sep; 12(9):1091-5. PubMed ID: 7803557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative analysis of mercaptoundecahydrododecaborate by Fourier transform infrared spectroscopy.
    Lu DR; Munro C
    Pharm Res; 1992 Sep; 9(9):1199-202. PubMed ID: 1409404
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intracellular targeting of sodium mercaptoundecahydrododecaborate (BSH) to solid tumors by transferrin-PEG liposomes, for boron neutron-capture therapy (BNCT).
    Maruyama K; Ishida O; Kasaoka S; Takizawa T; Utoguchi N; Shinohara A; Chiba M; Kobayashi H; Eriguchi M; Yanagie H
    J Control Release; 2004 Aug; 98(2):195-207. PubMed ID: 15262412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design, Synthesis, and Evaluation of Lipopeptide Conjugates of Mercaptoundecahydrododecaborate for Boron Neutron Capture Therapy.
    Isono A; Tsuji M; Sanada Y; Matsushita A; Masunaga S; Hirayama T; Nagasawa H
    ChemMedChem; 2019 Apr; 14(8):823-832. PubMed ID: 30707500
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics and boron uptake of BSH (Na2B12H11SH) in patients with intracranial tumors.
    Kageji T; Nakagawa Y; Kitamura K; Matsumoto K; Hatanaka H
    J Neurooncol; 1997 May; 33(1-2):117-30. PubMed ID: 9151229
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New strategy for synthesis of mercaptoundecahydrododecaborate derivatives via click chemistry: possible boron carriers and visualization in cells for neutron capture therapy.
    El-Zaria ME; Nakamura H
    Inorg Chem; 2009 Dec; 48(24):11896-902. PubMed ID: 19928788
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New functionalized mercaptoundecahydrododecaborate derivatives for potential application in boron neutron capture therapy: synthesis, characterization and dynamic visualization in cells.
    Genady AR; Ioppolo JA; Azaam MM; El-Zaria ME
    Eur J Med Chem; 2015 Mar; 93():574-83. PubMed ID: 25748122
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of high boron content liposomes and their promising antitumor effect for neutron capture therapy of cancers.
    Koganei H; Ueno M; Tachikawa S; Tasaki L; Ban HS; Suzuki M; Shiraishi K; Kawano K; Yokoyama M; Maitani Y; Ono K; Nakamura H
    Bioconjug Chem; 2013 Jan; 24(1):124-32. PubMed ID: 23214414
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Boron neutron capture therapy of brain tumors: enhanced survival following intracarotid injection of either sodium borocaptate or boronophenylalanine with or without blood-brain barrier disruption.
    Barth RF; Yang W; Rotaru JH; Moeschberger ML; Joel DD; Nawrocky MM; Goodman JH; Soloway AH
    Cancer Res; 1997 Mar; 57(6):1129-36. PubMed ID: 9067283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Boron neutron capture therapy of brain tumors: biodistribution, pharmacokinetics, and radiation dosimetry sodium borocaptate in patients with gliomas.
    Goodman JH; Yang W; Barth RF; Gao Z; Boesel CP; Staubus AE; Gupta N; Gahbauer RA; Adams DM; Gibson CR; Ferketich AK; Moeschberger ML; Soloway AH; Carpenter DE; Albertson BJ; Bauer WF; Zhang MZ; Wang CC
    Neurosurgery; 2000 Sep; 47(3):608-21; discussion 621-2. PubMed ID: 10981748
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Boron-enriched streptavidin potentially useful as a component of boron carriers for neutron capture therapy of cancer.
    Sano T
    Bioconjug Chem; 1999; 10(5):905-11. PubMed ID: 10502360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Boron neutron capture therapy of brain tumors: investigation of urinary metabolites and oxidation products of sodium borocaptate by electrospray ionization mass spectrometry.
    Gibson CR; Staubus AE; Barth RF; Yang W; Kleinholz NM; Jones RB; Green-Church K; Tjarks W; Soloway AH
    Drug Metab Dispos; 2001 Dec; 29(12):1588-98. PubMed ID: 11717178
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.